<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-viruses-11-00322">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chang</surname>
    <given-names>L.J.</given-names>
   </name>
   <name>
    <surname>Dowd</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Mendoza</surname>
    <given-names>F.H.</given-names>
   </name>
   <name>
    <surname>Saunders</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Sitar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Plummer</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Yamshchikov</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sarwar</surname>
    <given-names>U.N.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Enama</surname>
    <given-names>M.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: A phase 1 dose-escalation trial</article-title>
  <source>Lancet</source>
  <year>2014</year>
  <volume>384</volume>
  <fpage>2046</fpage>
  <lpage>2052</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(14)61185-5</pub-id>
  <pub-id pub-id-type="pmid">25132507</pub-id>
 </element-citation>
</ref>
